{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:38:22Z","timestamp":1790678302608,"version":"4.1.0"},"reference-count":287,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001230","name":"Macquarie University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australian Research Council Future Fellowship Award","award":["FT120100397"],"award-info":[{"award-number":["FT120100397"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.neuropharm.2016.05.011","type":"journal-article","created":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T13:38:07Z","timestamp":1464961087000},"page":"346-364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"PB","title":["Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosis"],"prefix":"10.1016","volume":"112","author":[{"given":"Jong-Min","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lovejoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nady","family":"Braidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic B.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce J.","family":"Brew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8105-4470","authenticated-orcid":false,"given":"Gilles J.","family":"Guillemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2016.05.011_bib1","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1158\/0008-5472.CAN-12-0549","article-title":"The kynurenine pathway in brain tumor pathogenesis","volume":"72","author":"Adams","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1474-4422(10)70068-5","article-title":"Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial","volume":"9","author":"Aggarwal","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib3","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.neuro.2007.07.010","article-title":"Time-related changes in constitutive and inducible nitric oxide synthases in the rat striatum in a model of Huntington's disease","volume":"28","author":"Aguilera","year":"2007","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-4613-0381-7_28","article-title":"Regulation of the kynurenine pathway by IFN-gamma in murine cloned macrophages and microglial cells","volume":"398","author":"Alberati-Giani","year":"1996","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib5","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1212\/WNL.57.7.1282","article-title":"Immune reactivity in a mouse model of familial ALS correlates with disease progression","volume":"57","author":"Alexianu","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2015.00289","article-title":"Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration","volume":"9","author":"Alves","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12640-011-9265-8","article-title":"New strategies in neuroprotection and neurorepair","volume":"21","author":"Antonelli","year":"2013","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib8","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","article-title":"TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"351","author":"Arai","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.gene.2007.04.010","article-title":"Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice","volume":"396","author":"Ball","year":"2007","journal-title":"Gene"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib10","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1111\/j.1742-4658.2011.08256.x","article-title":"TDP-43: the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration","volume":"278","author":"Baloh","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib11","first-page":"197","article-title":"Antibodies against microglia\/brain macrophages in the cerebrospinal fluid of a patient with acute amyotrophic lateral sclerosis and presenile dementia","volume":"14","author":"Banati","year":"1995","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.brainresrev.2004.05.003","article-title":"A\u00a0role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis","volume":"47","author":"Barbeito","year":"2004","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.freeradbiomed.2009.11.018","article-title":"Oxidative stress in ALS: key role in motor neuron injury and therapeutic target","volume":"48","author":"Barber","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nchembio.1563","article-title":"Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models","volume":"10","author":"Barmada","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/mus.20376","article-title":"Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis","volume":"32","author":"Baron","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/0141076813511451","article-title":"Advances in motor neurone disease","volume":"107","author":"B\u00e4umer","year":"2014","journal-title":"J.\u00a0R. Soc. Med."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-510X(01)00627-X","article-title":"Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity","volume":"191","author":"Bendotti","year":"2001","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/BF00370302","article-title":"Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre","volume":"419","author":"Benoit","year":"1991","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A\u00a0controlled trial of riluzole in amyotrophic lateral sclerosis. ALS\/Riluzole Study Group","volume":"330","author":"Bensimon","year":"1994","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib20","doi-asserted-by":"crossref","first-page":"e61177","DOI":"10.1371\/journal.pone.0061177","article-title":"Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis","volume":"8","author":"Berry","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib21","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00401-013-1125-6","article-title":"Protein aggregation in amyotrophic lateral sclerosis","volume":"125","author":"Blokhuis","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib22","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1046\/j.1471-4159.1997.69041629.x","article-title":"Energetic dysfunction in quinolinic acid-lesioned rat striatum","volume":"69","author":"Bordelon","year":"1997","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib23","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1111\/j.1471-4159.1993.tb07478.x","article-title":"Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis","volume":"61","author":"Bowling","year":"1993","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib24","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s11011-014-9557-9","article-title":"Changes in Cathepsin D and Beclin-1 mRNA and protein expression by the excitotoxin quinolinic acid in human astrocytes and neurons","volume":"29","author":"Braidy","year":"2014","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12640-009-9051-z","article-title":"Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons","volume":"16","author":"Braidy","year":"2009","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib26","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1742-4658.2009.07487.x","article-title":"Neuroprotective effects of naturally occurring polyphenols on quinolinic acid-induced excitotoxicity in human neurons","volume":"277","author":"Braidy","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib27","doi-asserted-by":"crossref","DOI":"10.4137\/IJTR.S2318","article-title":"Effects of kynurenine pathway metabolites on intracellular NAD+ synthesis and cell death in human primary astrocytes and neurons","author":"Braidy","year":"2009","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4137\/IJTR.S7052","article-title":"Effects of kynurenine pathway inhibition on NAD metabolism and cell viability in human primary astrocytes and neurons","volume":"4","author":"Braidy","year":"2011","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib29","first-page":"423","article-title":"TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord","author":"Brettschneider","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/13550289509111026","article-title":"Quinolinic acid production is related to macrophage tropic isolates of HIV-1","volume":"1","author":"Brew","year":"1995","journal-title":"J.\u00a0Neurovirol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00401-012-1058-5","article-title":"Unravelling the enigma of selective vulnerability in neurodegeneration: motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity","volume":"125","author":"Brockington","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.neuropharm.2016.05.011_bib32","first-page":"765","article-title":"FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis","volume":"22","author":"Broustal","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib33","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0896-6273(00)80272-X","article-title":"ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions","volume":"18","author":"Bruijn","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib34","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1126\/science.281.5384.1851","article-title":"Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1","volume":"281","author":"Bruijn","year":"1998","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib35","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1146\/annurev.neuro.27.070203.144244","article-title":"Unraveling the mechanisms involved in motor neuron degeneration in ALS","volume":"27","author":"Bruijn","year":"2004","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/hmg\/ddu415","article-title":"TDP-43 loss of cellular function through aggregation requires additional structural determinants beyond its C-terminal Q\/N prion-like domain","volume":"24","author":"Budini","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib37","doi-asserted-by":"crossref","first-page":"925101","DOI":"10.1155\/2014\/925101","article-title":"Amyotrophic lateral sclerosis: a focus on disease progression","volume":"2014","author":"Calvo","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jnutbio.2011.12.010","article-title":"Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity","volume":"24","author":"Carmona-Ram\u00edrez","year":"2013","journal-title":"J.\u00a0Nutr. Biochem."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib39","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1523\/JNEUROSCI.16-13-04069.1996","article-title":"Motor neurons are selectively vulnerable to AMPA\/kainate receptor-mediated injury in\u00a0vitro","volume":"16","author":"Carriedo","year":"1996","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib40","doi-asserted-by":"crossref","first-page":"e2849","DOI":"10.1371\/journal.pone.0002849","article-title":"Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALS","volume":"3","author":"Chang","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbrc.2012.10.009","article-title":"Natural inhibitors of indoleamine 3,5-dioxygenase induced by interferon-gamma in human neural stem cells","volume":"429","author":"Chen","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1750-3639.2011.00546.x","article-title":"Autophagy dysregulation in amyotrophic lateral sclerosis","volume":"22","author":"Chen","year":"2012","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib43","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1471-4159.2010.07159.x","article-title":"Characterization of the kynurenine pathway in NSC-34 cell line: implications for amyotrophic lateral sclerosis","volume":"118","author":"Chen","year":"2011","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib44","first-page":"1","article-title":"Kynurenine pathway metabolites in humans: disease and healthy states","volume":"61","author":"Chen","year":"2009","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/187152409787601941","article-title":"Recent advances in the treatment of amyotrophic lateral sclerosis. Emphasis on kynurenine pathway inhibitors","volume":"9","author":"Chen","year":"2009","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib46","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12640-009-9129-7","article-title":"The kynurenine pathway and inflammation in amyotropic lateral sclerosis","volume":"18","author":"Chen","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib47","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1471-4159.2011.07314.x","article-title":"Autophagy deregulation in neurodegenerative diseases - recent advances and future perspectives","volume":"118","author":"Cheung","year":"2011","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-510X(02)00339-8","article-title":"Low concentrations of glutamate induce apoptosis in cultured neurons: implications for amyotrophic lateral sclerosis","volume":"206","author":"Cid","year":"2003","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib49","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/1073858412444932","article-title":"Riluzole: what it does to spinal and brainstem neurons and how it does it","volume":"19","author":"Cifra","year":"2013","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02815200","article-title":"Species differences in the generation of reactive oxygen species by microglia","volume":"28","author":"Colton","year":"1996","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib51","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0306-3623(92)90017-E","article-title":"Nicotinylalanine increases cerebral kynurenic acid content and has anticonvulsant activity","volume":"23","author":"Connick","year":"1992","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib52","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1016\/0006-2952(86)90636-2","article-title":"The effect of kainic, quinolinic and beta-kainic acids on the release of endogenous amino acids from rat brain slices","volume":"35","author":"Connick","year":"1986","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib53","doi-asserted-by":"crossref","first-page":"11761","DOI":"10.1523\/JNEUROSCI.2734-09.2009","article-title":"Motoneuron transplantation rescues the phenotype of SMARD1 (spinal muscular atrophy with respiratory distress type 1)","volume":"29","author":"Corti","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0140-6736(93)92615-Z","article-title":"Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA\/kainate receptors","volume":"341","author":"Couratier","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib55","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/glia.10181","article-title":"Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulation","volume":"41","author":"Croitoru-Lamoury","year":"2003","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib56","doi-asserted-by":"crossref","first-page":"19871","DOI":"10.1016\/S0021-9258(17)45453-6","article-title":"Regulation of indoleamine 2,3-dioxygenase gene expression in human fibroblasts by interferon-gamma. Upstream control region discriminates between interferon-gamma and interferon-alpha","volume":"265","author":"Dai","year":"1990","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib57","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4137\/IJTR.S4321","article-title":"Tryptophan, neurodegeneration and HIV-associated neurocognitive disorder","volume":"3","author":"Davies","year":"2010","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib58","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib59","doi-asserted-by":"crossref","first-page":"7142","DOI":"10.1073\/pnas.0602046103","article-title":"Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria","volume":"103","author":"Deng","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib60","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0304-3940(92)90114-M","article-title":"Pertussis toxin pretreatment abolishes the inhibitory effect of riluzole and carbachol on D-[3H]aspartate release from cultured cerebellar granule cells","volume":"140","author":"Doble","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib61","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s11064-012-0820-3","article-title":"Cooperation of non-effective concentration of glutamatergic system modulators and antioxidant against oxidative stress induced by quinolinic acid","volume":"37","author":"Dobrachinski","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib62","first-page":"358","article-title":"RNA toxicity from the ALS\/FTD C9ORF72 expansion is mitigated by antisense intervention","volume":"127","author":"Donelly","year":"2012"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib63","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(98)00120-7","article-title":"Tryptophan and its metabolite, kynurenine, stimulate expression of nerve growth factor in cultured mouse astroglial cells","volume":"244","author":"Dong-Ruyl","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib64","first-page":"228","article-title":"Stimulation of NGF production by tryptophan and its metabolites in cultured mouse astroglial cells","volume":"777","author":"Dong-Ryul","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib65","doi-asserted-by":"crossref","first-page":"200","DOI":"10.12659\/MSMBR.893093","article-title":"Mast cells and neuroinflammation","volume":"20","author":"Dong","year":"2014","journal-title":"Med. Sci. Monit. Basic Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib66","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.neuroscience.2010.06.018","article-title":"Mutant TAR DNA-binding protein-43 induces oxidative injury in motor neuron-like cell","volume":"169","author":"Duan","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib67","doi-asserted-by":"crossref","first-page":"11159","DOI":"10.1073\/pnas.0402026101","article-title":"Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model","volume":"101","author":"Dupuis","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib68","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1474-4422(10)70224-6","article-title":"Energy metabolism in amyotrophic lateral sclerosis","volume":"10","author":"Dupuis","year":"2011","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib284","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-4615-0135-0_21","article-title":"T cell apoptosis by kynurenines","volume":"527","author":"Fallarino","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib69","doi-asserted-by":"crossref","first-page":"13416","DOI":"10.1038\/srep13416","article-title":"Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions","volume":"5","author":"Farrawell","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib70","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1006\/exnr.1993.1006","article-title":"Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization","volume":"119","author":"Ferrante","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib71","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1093\/hmg\/ddv104","article-title":"Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations","volume":"24","author":"Finelli","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib72","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/brain\/awq314","article-title":"SOD1 targeted to the mitochondrial intermembrane space prevents motor neuropathy in the Sod1 knockout mouse","volume":"134","author":"Fischer","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib73","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ana.1029","article-title":"Intron 7 retention and exon 9 skipping EAAT2 mRNA variants are not associated with amyotrophic lateral sclerosis","volume":"49","author":"Flowers","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib74","doi-asserted-by":"crossref","first-page":"16404","DOI":"10.1073\/pnas.0708022105","article-title":"Lithium delays progression of amyotrophic lateral sclerosis Francesco","volume":"105","author":"Fornai","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib75","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1046\/j.1460-9568.1998.00273.x","article-title":"The expression of the glial glutamate transporter protein EAAT2 in motor neuron disease: an immunohistochemical study","volume":"10","author":"Fray","year":"1998","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2016.05.011_bib285","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.20020121","article-title":"Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase","volume":"196","author":"Frumento","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib76","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1007\/s12035-013-8620-6","article-title":"Phagocytosis of microglia in the central nervous system diseases","volume":"49","author":"Fu","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib77","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/abbi.1998.0861","article-title":"Species differences in L-tryptophan-kynurenine pathway metabolism: quantification of anthranilic acid and its related enzymes","volume":"358","author":"Fujigaki","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib78","first-page":"82","article-title":"Mice overexpressing both non-mutated human SOD1 and mutated SOD1(G93A) genes: a competent experimental model for studying iron metabolism in amyotrophic lateral sclerosis","volume":"8","author":"Gajowiak","year":"2015","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib79","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0006-8993(90)90636-P","article-title":"Quinolinate and kainate neurotoxicity in neostriatal cultures is potentiated by co-culturing with neocortical neurons","volume":"512","author":"Galarraga","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib80","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.neures.2006.05.003","article-title":"Time course of oxidative events in the hippocampus following intracerebroventricular infusion of quinolinic acid in mice","volume":"55","author":"Ganzella","year":"2006","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib81","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/jnr.23595","article-title":"Absence of aryl hydrocarbon receptors increases endogenous kynurenic acid levels and protects mouse brain against excitotoxic insult and oxidative stress","volume":"93","author":"Garc\u00eda-Lara","year":"2015","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib82","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1126\/science.2148832","article-title":"Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1","volume":"250","author":"Giulian","year":"1990","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib83","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib84","doi-asserted-by":"crossref","first-page":"e17808","DOI":"10.1371\/journal.pone.0017808","article-title":"TDP-43 regulates Drosophila neuromuscular junctions growth by modulating Futsch\/MAP1B levels and synaptic microtubules organization","volume":"6","author":"Godena","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib85","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.1021\/bi992997s","article-title":"3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction","volume":"39","author":"Goldstein","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib86","doi-asserted-by":"crossref","first-page":"295","DOI":"10.14336\/AD.2013.0400295","article-title":"Amyotrophic lateral sclerosis: an update for 2013 clinical features, pathophysiology, management and therapeutic trials","volume":"4","author":"Gordon","year":"2013","journal-title":"Aging Dis."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib87","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(07)70270-3","article-title":"Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial","volume":"6","author":"Gordon","year":"2007","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib88","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/14660820410020286","article-title":"Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells","volume":"5","author":"Graves","year":"2004","journal-title":"Amyotroph. Lateral Scler. Other Mot. Neuron Disord."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib89","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-1-4615-0135-0_16","article-title":"3-Hydroxykynurenine and quinolinate: pathogenic synergism in early grade Huntington's disease?","volume":"527","author":"Guidetti","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib90","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1179\/135100002125000550","article-title":"Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease","volume":"7","author":"Guillemin","year":"2002","journal-title":"Redox Rep."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib91","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2990.2005.00655.x","article-title":"Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus","volume":"31","author":"Guillemin","year":"2005","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib92","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/glia.10175","article-title":"Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes","volume":"41","author":"Guillemin","year":"2003","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib93","doi-asserted-by":"crossref","first-page":"12884","DOI":"10.1523\/JNEUROSCI.4101-07.2007","article-title":"Characterization of the kynurenine pathway in human neurons","volume":"27","author":"Guillemin","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib94","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF03033781","article-title":"Involvement of quinolinic acid in AIDS dementia complex","volume":"7","author":"Guillemin","year":"2005","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib95","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","article-title":"Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection","volume":"78","author":"Guillemin","year":"2001","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib96","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000089622","article-title":"Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis","volume":"2","author":"Guillemin","year":"2005","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib97","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1179\/135100000101535375","article-title":"Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis","volume":"5","author":"Guillemin","year":"2000","journal-title":"Redox Rep."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib98","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1097\/00001756-200312190-00005","article-title":"A\u00a0beta 1-42 induces production of quinolinic acid by human macrophages and microglia","volume":"14","author":"Guillemin","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib99","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-2094-2-16","article-title":"Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex","volume":"2","author":"Guillemin","year":"2005","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib100","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nm.3457","article-title":"Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases","volume":"20","author":"Guo","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib101","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1097-4547(19980701)53:1<66::AID-JNR7>3.0.CO;2-H","article-title":"Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS","volume":"53","author":"Hall","year":"1998","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib102","doi-asserted-by":"crossref","first-page":"19392","DOI":"10.1016\/S0021-9258(19)77645-5","article-title":"Neutral amino acid transport at the human blood-brain barrier","volume":"263","author":"Hargreaves","year":"1988","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib103","first-page":"199","article-title":"Specific induction of pulmonary indoleamine 2,3-dioxygenase by bacterial lipopolysaccharide","author":"Hayaishi","year":"1978","journal-title":"Ciba Found. Symp."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib104","doi-asserted-by":"crossref","unstructured":"Henkel, J.S., Engelhardt, J.I., Kim, S.H., Pan, T., Goodman, J.C., Siddique, T., Beers, D.R., Appel, S.H., 2003. Presence of dendritic cells, MCP-1, and activated microglia\/macrophages in amyotrophic lateral sclerosis spinal cord tissue, 221\u2013235.","DOI":"10.1002\/ana.10805"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ana.10805","article-title":"Presence of dendritic cells, MCP-1, and activated microglia\/macrophages in amyotrophic lateral sclerosis spinal cord tissue","volume":"55","author":"Henkel","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib106","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0969-9961(03)00087-1","article-title":"Message and protein-level elevation of tumor necrosis factor alpha (TNF alpha) and TNF alpha-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis","volume":"14","author":"Hensley","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib107","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1471-4159.2002.00968.x","article-title":"Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis","volume":"82","author":"Hensley","year":"2002","journal-title":"J.\u00a0Neurochem."},{"issue":"Pt 2","key":"10.1016\/j.neuropharm.2016.05.011_bib108","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1042\/bj3200595","article-title":"Human microglia convert l-tryptophan into the neurotoxin quinolinic acid","volume":"320","author":"Heyes","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib109","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/978-1-4684-5952-4_94","article-title":"Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome","volume":"294","author":"Heyes","year":"1991","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib110","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.410290215","article-title":"Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status","volume":"29","author":"Heyes","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib111","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1046\/j.1471-4159.1997.69041519.x","article-title":"Species heterogeneity between gerbils and rats: quinolinate production by microglia and astrocytes and accumulations in response to ischemic brain injury and systemic immune activation","volume":"69","author":"Heyes","year":"1997","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib112","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1212\/WNL.0b013e3181b26ae6","article-title":"Subcutaneous IGF-1 is not beneficial in 2-year ALS trial","volume":"73","author":"Howe","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib113","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1073\/pnas.032539299","article-title":"Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)","volume":"99","author":"Howland","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib114","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11011-015-9782-x","article-title":"Quinolinic acid induces cell apoptosis in PC12 cells through HIF-1-dependent RTP801 activation","author":"Huang","year":"2016","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib115","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.200908164","article-title":"Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond","volume":"187","author":"Ilieva","year":"2009","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib116","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1034\/j.1600-0404.2003.00076.x","article-title":"Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis","volume":"107","author":"Ilzecka","year":"2003","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib117","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1006\/nbdi.2000.0299","article-title":"Human Cu\/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SO","volume":"7","author":"Jaarsma","year":"2000","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib118","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1046\/j.1471-4159.1999.0730322.x","article-title":"Activation of caspase-3 in developmental models of programmed cell death in neurons of the substantia nigra","volume":"73","author":"Jeon","year":"1999","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib119","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0006-8993(90)90826-W","article-title":"Quinolinate-induced cortical cholinergic damage: modulation by tryptophan metabolites","volume":"529","author":"Jhamandas","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib120","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/hmg\/ddu605","article-title":"A\u00a0novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicity","volume":"24","author":"Joyce","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib121","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bbadis.2006.03.006","article-title":"Transgenic mouse models of amyotrophic lateral sclerosis","volume":"1762","author":"Julien","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib122","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1124\/pr.110.004036","article-title":"Exciting times beyond the brain: metabotropic glutamate receptors in peripheral and non-neural tissues","volume":"63","author":"Julio-Pieper","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib123","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.pnpbp.2011.01.003","article-title":"Licofelone attenuates quinolinic acid induced Huntington like symptoms: possible behavioral, biochemical and cellular alterations","volume":"35","author":"Kalonia","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib124","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.brainres.2010.11.060","article-title":"Attenuation of proinflammatory cytokines and apoptotic process by verapamil and diltiazem against quinolinic acid induced Huntington like alterations in rats","volume":"1372","author":"Kalonia","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib125","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12640-012-9315-x","article-title":"Targeting neuro-inflammatory cytokines and oxidative stress by minocycline attenuates quinolinic-acid-induced Huntington's disease-like symptoms in rats","volume":"22","author":"Kalonia","year":"2012","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib126","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.brainres.2004.04.044","article-title":"Effects of mitochondrial dysfunction on glutamate receptor-mediated neurotoxicity in cultured rat spinal motor neurons","volume":"1015","author":"Kanki","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib127","first-page":"691","article-title":"Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue","volume":"140","author":"Kawamata","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib128","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4137\/IJTR.S16800","article-title":"Imbalanced kynurenine pathway in schizophrenia","volume":"7","author":"Kegel","year":"2014","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib129","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/13550289509111027","article-title":"Neurocytotoxity of quinolinic acid in human brain cultures","volume":"1","author":"Kerr","year":"1995","journal-title":"J.\u00a0Neurovirol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib130","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00002030-199804000-00003","article-title":"Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex","volume":"12","author":"Kerr","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib131","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/jnr.490220207","article-title":"Neurotoxic effect induced by quinolinic acid in dissociated cell culture of mouse hippocampus","volume":"22","author":"Khaspekov","year":"1989","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib132","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0306-4522(87)90066-2","article-title":"Quinolinate neurotoxicity in cortical cell culture","volume":"23","author":"Kim","year":"1987","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib133","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/neup.12020","article-title":"Neural stem cell-based treatment for neurodegenerative diseases","volume":"33","author":"Kim","year":"2013","journal-title":"Neuropathology"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib134","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1089\/neu.2005.22.1142","article-title":"The uncoupling agent 2,4-dinitrophenol improves mitochondrial homeostasis following striatal quinolinic acid injections","volume":"22","author":"Korde","year":"2005","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib135","first-page":"357","article-title":"Microglia, the first line of defence in brain pathologies","volume":"45","author":"Kreutzberg","year":"1995","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib136","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF01184069","article-title":"Co-induction of neuronal interferon-gamma and nitric oxide synthase in rat motor neurons after axotomy: a role in nerve repair or death?","volume":"23","author":"Kristensson","year":"1994","journal-title":"J.\u00a0Neurocytol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib137","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/2051-5960-1-24","article-title":"Amyotrophic lateral sclerosis (ALS)-associated VAPB-P56S inclusions represent an ER quality control compartment","volume":"1","author":"Kuijpers","year":"2013","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib138","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejphar.2013.10.057","article-title":"Minocycline modulates neuroprotective effect of hesperidin against quinolinic acid induced Huntington's disease like symptoms in rats: behavioral, biochemical, cellular and histological evidences","volume":"720","author":"Kumar","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib139","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.1166066","article-title":"Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis","volume":"323","author":"Kwiatkowski","year":"2009","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib140","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","article-title":"Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis\/Riluzole Study Group II","volume":"347","author":"Lacomblez","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib141","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1093\/hmg\/ddq137","article-title":"TDP-43 and FUS\/TLS: emerging roles in RNA processing and neurodegeneration","volume":"19","author":"Lagier-Tourenne","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib142","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/340731","article-title":"Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1\/p62) in Paget disease of bone","volume":"70","author":"Laurin","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib143","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3109\/17482968.2011.619197","article-title":"Biochemical alterations associated with ALS","volume":"13","author":"Lawton","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib144","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00401-009-0560-x","article-title":"The ubiquitin proteasome system in neuropathology","volume":"118","author":"Lehman","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib145","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/ene.12344","article-title":"A\u00a0phase II-III trial of olesoxime in subjects with amyotrophic lateral sclerosis","volume":"21","author":"Lenglet","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib146","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4161\/auto.5524","article-title":"Altered macroautophagy in the spinal cord of SOD1 mutant mice","volume":"4","author":"Li","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib147","doi-asserted-by":"crossref","DOI":"10.4137\/IJTR.S4294","article-title":"Understanding the roles of the kynurenine pathway in multiple sclerosis progression","author":"Lim","year":"2010","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib148","article-title":"Altered kynurenine pathway metabolism in autism: implication for immune-induced glutamatergic activity","author":"Lim","year":"2015","journal-title":"Autism Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib149","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ics.2007.07.011","article-title":"Characterization of the kynurenine pathway in human oligodendrocytes","volume":"1304","author":"Lim","year":"2007","journal-title":"Int. Congr. Ser."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib150","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0896-6273(00)80997-6","article-title":"Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis","volume":"20","author":"Lin","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib151","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/glia.22639","article-title":"Effects of dextromethorphan on glial cell function: proliferation, maturation, and protection from cytotoxic molecules","volume":"62","author":"Lisak","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib152","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/104024","article-title":"Quinolinic acid: an endogenous neurotoxin with multiple targets","volume":"2013","author":"Lugo-Huitron","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib153","doi-asserted-by":"crossref","first-page":"8117","DOI":"10.1073\/pnas.91.17.8117","article-title":"Apoptosis in substantia nigra following developmental striatal excitotoxic injury","volume":"91","author":"Macaya","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-009-0612-2","article-title":"Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update","volume":"119","author":"Mackenzie","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib155","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.21147","article-title":"Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations","volume":"61","author":"Mackenzie","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib156","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S1474-4422(10)70195-2","article-title":"TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"9","author":"Mackenzie","year":"2010","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib157","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1002\/jnr.21178","article-title":"L-NAME reverses quinolinic acid-induced toxicity in rat corticostriatal slices: involvement of src family kinases","volume":"85","author":"Mallozzi","year":"2007","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib158","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ncpneuro0355","article-title":"Mechanisms of Disease: astrocytes in neurodegenerative disease","volume":"2","author":"Maragakis","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib159","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.nbd.2003.12.007","article-title":"Glutamate transporters: animal models to neurologic disease","volume":"15","author":"Maragakis","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib160","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0014-2999(93)90037-I","article-title":"The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1","volume":"250","author":"Martin","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib161","doi-asserted-by":"crossref","first-page":"29626","DOI":"10.1074\/jbc.M203065200","article-title":"Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice","volume":"277","author":"Mattiazzi","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib162","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.expneurol.2013.08.007","article-title":"The absence of indoleamine 2,3-dioxygenase expression protects against NMDA receptor-mediated excitotoxicity in mouse brain","volume":"249","author":"Mazarei","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib163","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1016\/S0021-9258(18)63504-5","article-title":"Superoxide dismutase","volume":"244","author":"McCord","year":"1969","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib164","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/mus.10191","article-title":"Inflammatory processes in amyotrophic lateral sclerosis","volume":"26","author":"McGeer","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib165","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/ana.23780","article-title":"Early interneuron dysfunction in ALS: insights from a mutant sod1 zebrafish model","volume":"73","author":"McGown","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib166","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1016\/S0021-9258(18)97049-3","article-title":"Binding of indole analogues to human serum albumin. Effects of fatty acids","volume":"240","author":"McMenamy","year":"1965","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib167","doi-asserted-by":"crossref","first-page":"7082","DOI":"10.1158\/0008-5472.CAN-07-1872","article-title":"Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan","volume":"67","author":"Metz","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib168","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0022-510X(99)00196-3","article-title":"The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals","volume":"170","author":"Meyer","year":"1999","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib169","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/00005072-199712000-00006","article-title":"c-Jun, JNK\/SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis","volume":"56","author":"Migheli","year":"1997","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib170","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.nbd.2003.12.015","article-title":"Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia","volume":"15","author":"Miller","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib171","first-page":"191","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","volume":"3","author":"Miller","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib172","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1474-4422(13)70061-9","article-title":"An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study","volume":"12","author":"Miller","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib173","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0169-328X(97)00233-7","article-title":"Expression of the glial glutamate transporter EAAT2 in the human CNS: an immunohistochemical study","volume":"52","author":"Milton","year":"1997","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib174","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.pharep.2014.07.006","article-title":"Improvement of mitochondrial NAD(+)\/FAD(+)-linked state-3 respiration by caffeine attenuates quinolinic acid induced motor impairment in rats: implications in Huntington's disease","volume":"66","author":"Mishra","year":"2014","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib175","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S1474-4422(14)70129-2","article-title":"Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?","volume":"13","author":"Mitsumoto","year":"2014","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.neuropharm.2016.05.011_bib286","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/exnr.1996.6365","article-title":"Quinolinate immunoreactivity in experimental rat brain tumors is present in macrophages but not in astrocytes","volume":"144","author":"Moffett","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib176","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.neuropharm.2012.02.021","article-title":"Social isolation rearing in rats alters plasma tryptophan metabolism and is reversed by sub-chronic clozapine treatment","volume":"62","author":"M\u00f6ller","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib177","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.brainres.2007.06.045","article-title":"Increased autophagy in transgenic mice with a G93A mutant SOD1 gene","volume":"1167","author":"Morimoto","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib178","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nn1876","article-title":"Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons","volume":"10","author":"Nagai","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib179","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1089\/ars.2009.2991","article-title":"Amyotrophic lateral sclerosis pathogenesis: a journey through the secretory pathway","volume":"13","author":"Nassif","year":"2010","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib180","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib181","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1086\/425287","article-title":"A\u00a0mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis","volume":"75","author":"Nishimura","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib182","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/(SICI)1098-1136(199808)23:4<285::AID-GLIA1>3.0.CO;2-2","article-title":"Differential expression of superoxide dismutase isoforms in neuronal and glial compartments in the course of excitotoxically mediated neurodegeneration: relation to oxidative and nitrergic stress","volume":"23","author":"Noack","year":"1998","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib183","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s007260070061","article-title":"In\u00a0vivo assessment of kynurenate neuroprotective potency and quinolinate excitotoxicity","volume":"19","author":"Obrenovitch","year":"2000","journal-title":"Amino Acids"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib184","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00234911","article-title":"Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system","volume":"14","author":"Olney","year":"1971","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib185","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1523\/JNEUROSCI.09-11-03870.1989","article-title":"Gamma-interferon-like immunoreactivity in axotomized rat motor neurons","volume":"9","author":"Olsson","year":"1989","journal-title":"J.\u00a0Neuroscience"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib186","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/j.1471-4159.2008.05241.x","article-title":"Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity","volume":"105","author":"Owe-Young","year":"2008","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib187","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.nbd.2009.10.005","article-title":"Inflammation in ALS and SMA: sorting out the good from the evil","volume":"37","author":"Papadimitriou","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib188","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1471-4159.2004.02357.x","article-title":"Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis","volume":"89","author":"Pehar","year":"2004","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib189","first-page":"1","article-title":"Quinolinic Acid, an endogenous molecule combining excitotoxicity, oxidative stress and other toxic mechanisms","volume":"5","author":"Perez-De La Cruz","year":"2012","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib190","first-page":"551","article-title":"Pharmacology and regional variations of quinolinic acid-evoked excitations in the rat central nervous system","volume":"226","author":"Perkins","year":"1983","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib191","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0006-8993(82)91048-4","article-title":"An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid","volume":"247","author":"Perkins","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib192","doi-asserted-by":"crossref","first-page":"878030","DOI":"10.1155\/2012\/878030","article-title":"Nrf2\/ARE signaling pathway: key mediator in oxidative stress and potential therapeutic target in ALS","volume":"2012","author":"Petri","year":"2012","journal-title":"Neurol. Res. Int."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib193","first-page":"2190","article-title":"The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice","volume":"118","author":"Pickford","year":"2008","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib194","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.expneurol.2010.03.009","article-title":"Acute intrastriatal administration of quinolinic acid provokes hyperphosphorylation of cytoskeletal intermediate filament proteins in astrocytes and neurons of rats","volume":"224","author":"Pierozan","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib195","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ana.410220503","article-title":"Abnormal glutamate metabolism in amyotrophic lateral sclerosis","volume":"22","author":"Plaitakis","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib196","doi-asserted-by":"crossref","first-page":"e35050","DOI":"10.1371\/journal.pone.0035050","article-title":"Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis","volume":"7","author":"Pokrishevsky","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib197","doi-asserted-by":"crossref","first-page":"128","DOI":"10.5482\/HAMO-14-10-0052","article-title":"The role of the kynurenine pathway of tryptophan metabolism in cardiovascular disease. An emerging field","volume":"35","author":"Polyzos","year":"2015","journal-title":"H\u00e4mostaseologie"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib198","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/(SICI)1096-9861(19970203)378:1<88::AID-CNE5>3.0.CO;2-G","article-title":"Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: further evidence for an apoptosis- necrosis continuum","volume":"378","author":"Portera-Cailliau","year":"1997","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib199","first-page":"841","article-title":"Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a\/NR2A and NR1a\/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells","volume":"48","author":"Priestley","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.nrl.0000106920.84668.37","article-title":"Programmed cell death in amyotrophic lateral sclerosis: a mechanism of pathogenic and therapeutic importance","volume":"10","author":"Przedborski","year":"2004","journal-title":"Neurologist"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib201","doi-asserted-by":"crossref","first-page":"e6344","DOI":"10.1371\/journal.pone.0006344","article-title":"The excitotoxin quinolinic acid induces tau phosphorylation in human neurons","volume":"4","author":"Rahman","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib202","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.expneurol.2006.05.001","article-title":"Does excitotoxic cell death of motor neurons in ALS arise from glutamate transporter and glutamate receptor abnormalities?","volume":"201","author":"Rattray","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib203","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A\u00a0hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib204","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/j.1471-4159.2006.04199.x","article-title":"Evidence that quinolinic acid severely impairs energy metabolism through activation of NMDA receptors in striatum from developing rats","volume":"99","author":"Ribeiro","year":"2006","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib205","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.brainres.2014.09.017","article-title":"Induced pluripotent stem cells from ALS patients for disease modeling","volume":"1607","author":"Richard","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib206","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/BF00966592","article-title":"Quinolinic acid is a potent lipid peroxidant in rat brain homogenates","volume":"16","author":"Rios","year":"1991","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib207","doi-asserted-by":"crossref","first-page":"525097","DOI":"10.1155\/2014\/525097","article-title":"Blood biomarkers for amyotrophic lateral sclerosis: myth or reality?","volume":"2014","author":"Robelin","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib208","doi-asserted-by":"crossref","first-page":"e47838","DOI":"10.1371\/journal.pone.0047838","article-title":"Role of disulfide cross-linking of mutant SOD1 in the formation of inclusion-body-like structures","volume":"7","author":"Roberts","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib209","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2014.00024","article-title":"Astrocytes expressing mutant SOD1 and TDP43 trigger motoneuron death that is mediated via sodium channels and nitroxidative stress","volume":"8","author":"Rojas","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib211","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s13311-014-0332-8","article-title":"Challenges in the understanding and treatment of amyotrophic lateral sclerosis\/motor neuron disease","author":"Rosenfeld","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2013.00253","article-title":"An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis","volume":"7","author":"Rotunno","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406000068","article-title":"Tryptophan metabolism in the central nervous system: medical implications","volume":"8","author":"Ruddick","year":"2006","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib214","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1042\/bj2290499","article-title":"The role of tryptophan 2,3-dioxygenase in the hormonal control of tryptophan metabolism in isolated rat liver cells. Effects of glucocorticoids and experimental diabetes","volume":"229","author":"Salter","year":"1985","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib215","first-page":"233","article-title":"Distribution of the N-methyl-D-aspartate glutamate receptor subunit NR2A in control and amyotrophic lateral sclerosis spinal cord","volume":"727","author":"Samarasinghe","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib216","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/00001756-200103260-00049","article-title":"Quinolinic acid induces oxidative stress in rat brain synaptosomes","volume":"12","author":"Santamaria","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib217","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/glia.20210","article-title":"Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis","volume":"51","author":"Sargsyan","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib218","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/NEN.0b013e31818b4906","article-title":"Nuclear erythroid 2-related factor 2-antioxidative response element signaling pathway in motor cortex and spinal cord in amyotrophic lateral sclerosis","volume":"67","author":"Sarlette","year":"2008","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib219","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jns.2007.01.033","article-title":"Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders","volume":"257","author":"Sas","year":"2007","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib220","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/NEN.0b013e3182160690","article-title":"Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis","volume":"70","author":"Sasaki","year":"2011","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib221","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.0305-1846.2001.00332.x","article-title":"Apoptosis in amyotrophic lateral sclerosis: a review of the evidence","volume":"27","author":"Sathasivam","year":"2001","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib222","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pneurobio.2009.04.005","article-title":"Of mice, rats and men: revisiting the quinolinic acid hypothesis of Huntington's disease","volume":"90","author":"Schwarcz","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib223","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0304-3940(83)90115-5","article-title":"Differential vulnerability of central neurons of the rat to quinolinic acid","volume":"38","author":"Schwarcz","year":"1983","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib224","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.6849138","article-title":"Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain","volume":"219","author":"Schwarcz","year":"1983","journal-title":"Science (80-. )"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib225","article-title":"[Role of caspases in neural degeneration in amyotrophic lateral sclerosis]","volume":"140","author":"Sela","year":"2001","journal-title":"Harefuah"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib226","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/sj.mp.4001463","article-title":"Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease","volume":"9","author":"Senatorov","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib227","doi-asserted-by":"crossref","first-page":"16325","DOI":"10.1073\/pnas.1003459107","article-title":"Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice","volume":"107","author":"Shan","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl.\u00a0l","key":"10.1016\/j.neuropharm.2016.05.011_bib228","first-page":"I17","article-title":"Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis","volume":"247","author":"Shaw","year":"2000","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib229","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/neur.1995.0026","article-title":"CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients","volume":"4","author":"Shaw","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib230","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0006-8993(01)02926-2","article-title":"Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients","volume":"917","author":"Shibata","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib231","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2967\/jnumed.110.084046","article-title":"In\u00a0vivo expression of cyclooxygenase-1 in activated microglia and macrophages during neuroinflammation visualized by PET with 11C-ketoprofen methyl ester","volume":"52","author":"Shukuri","year":"2011","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib232","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.62.10.1758","article-title":"Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden","volume":"62","author":"Simpson","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib233","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/ana.410440419","article-title":"Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis","volume":"44","author":"Smith","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib234","doi-asserted-by":"crossref","DOI":"10.2144\/02323dd02","article-title":"Markers of apoptosis: methods for elucidating the mechanism of apoptotic cell death from the nervous system","volume":"32","author":"Smyth","year":"2002","journal-title":"Biotechniques"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib235","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.nbd.2003.11.012","article-title":"Cu\/Zn-superoxide dismutase (GLY93-->ALA) mutation alters AMPA receptor subunit expression and function and potentiates kainate-mediated toxicity in motor neurons in culture","volume":"15","author":"Spalloni","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib236","doi-asserted-by":"crossref","first-page":"13578","DOI":"10.1523\/JNEUROSCI.4390-09.2009","article-title":"Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases","volume":"29","author":"Spencer","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib237","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-510X(01)00661-X","article-title":"Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients","volume":"193","author":"Spreux-Varoquaux","year":"2002","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib238","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib239","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00702-011-0694-6","article-title":"Regulation of quinolinic acid neosynthesis in mouse, rat and human brain by iron and iron chelators in\u00a0vitro","volume":"119","author":"Stachowski","year":"2012","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib240","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0041-0101(00)00156-2","article-title":"Endogenous neurotoxins from tryptophan","volume":"39","author":"Stone","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib241","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1742-4658.2012.08487.x","article-title":"Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection","volume":"279","author":"Stone","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib242","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.neurobiolaging.2007.04.006","article-title":"Synuclein activates microglia in a model of Parkinson's disease","volume":"29","author":"Su","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib243","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1007\/s00018-013-1385-2","article-title":"Extracellular wildtype and mutant SOD1 induces ER-Golgi pathology characteristic of amyotrophic lateral sclerosis in neuronal cells","volume":"70","author":"Sundaramoorthy","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2016.05.011_bib244","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.freeradbiomed.2014.10.820","article-title":"Oxidative stress affects FET proteins localization and alternative pre-mRNA processing in cellular models of ALS","volume":"75","author":"Svetoni","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib245","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jns.2011.07.021","article-title":"Altered tryptophan metabolism in Parkinson's disease: a possible novel therapeutic approach","volume":"310","author":"Szab\u00f3","year":"2011","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib246","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbrc.2005.09.032","article-title":"Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism","volume":"338","author":"Takikawa","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib247","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/978-1-4615-4709-9_68","article-title":"Interferon-gamma-dependent\/independent expression of indoleamine 2,3-dioxygenase. Studies with interferon-gamma-knockout mice","volume":"467","author":"Takikawa","year":"1999","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib248","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1016\/S0021-9258(17)35696-X","article-title":"Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase","volume":"261","author":"Takikawa","year":"1986","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib249","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000243650","article-title":"Protective effect of tert-butylhydroquinone on the quinolinic-acid-induced toxicity in rat striatal slices: role of the Nrf2-antioxidant response element pathway","volume":"18","author":"Tasset","year":"2010","journal-title":"Neurosignals"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib250","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0197-0186(01)00133-4","article-title":"Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes","volume":"40","author":"Tavares","year":"2002","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib251","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00001756-200002070-00005","article-title":"Quinolinic acid inhibits glutamate uptake into synaptic vesicles from rat brain","volume":"11","author":"Tavares","year":"2000","journal-title":"Neuroreport"},{"issue":"4","key":"10.1016\/j.neuropharm.2016.05.011_bib287","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1084\/jem.20020052","article-title":"Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites","volume":"196","author":"Terness","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib252","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1742-2094-6-36","article-title":"Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease","volume":"6","author":"Ting","year":"2009","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib253","first-page":"225","article-title":"Encapsulated cell-based biodelivery of meteorin is neuroprotective in the quinolinic acid rat model of neurodegenerative disease","volume":"30","author":"Torn\u00f8e","year":"2012","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib254","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11910-010-0160-0","article-title":"Research advances in amyotrophic lateral sclerosis, 2009 to 2010","volume":"11","author":"Traub","year":"2011","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2012.08.050","article-title":"Protective effect of N,N\u2019-dialkylated analogs of 4,4'-diaminodiphenylsulfone in a model of intrastriatal quinolinic acid induced-excitotoxicity","volume":"528","author":"Trist\u00e1n-L\u00f3pez","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib256","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1365-2990.1993.tb00459.x","article-title":"Neuronophagia in the motor cortex in amyotrophic lateral sclerosis","volume":"19","author":"Troost","year":"1993","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2016.05.011_bib257","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/21678421.2013.778554","article-title":"Mechanisms, models and biomarkers in amyotrophic lateral sclerosis","volume":"14","author":"Turner","year":"2013","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib258","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1474-4422(13)70036-X","article-title":"Controversies and priorities in amyotrophic lateral sclerosis","volume":"12","author":"Turner","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib259","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/practneurol-2013-000557","article-title":"Mimics and chameleons in motor neurone disease","volume":"13","author":"Turner","year":"2013","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib260","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/157015909787602823","article-title":"Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options","volume":"7","author":"Uttara","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib261","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1474-4422(08)70071-1","article-title":"TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis","volume":"7","author":"Van Deerlin","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib262","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.1165942","article-title":"Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6","volume":"323","author":"Vance","year":"2009","journal-title":"Science (80-. )"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib263","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/mus.23673","article-title":"RNA quality control and protein aggregates in amyotrophic lateral sclerosis: a review","volume":"47","author":"Verma","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib264","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00401-004-0977-1","article-title":"Sublethal dose of 4-hydroxynonenal reduces intracellular calcium in surviving motor neurons in\u00a0vivo","volume":"109","author":"Vigh","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib265","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/hmg\/ddp085","article-title":"Wild-type SOD1 overexpression accelerates disease onset of a G85R SOD1 mouse","volume":"18","author":"Wang","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib266","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1111\/j.1460-9568.2005.04431.x","article-title":"Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model","volume":"22","author":"Wang","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib267","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1750-1326-6-75","article-title":"Generation and characterization of transgenic mice expressing mitochondrial targeted red fluorescent protein selectively in neurons: modeling mitochondriopathy in excitotoxicity and amyotrophic lateral sclerosis","volume":"6","author":"Wang","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib268","first-page":"1","article-title":"Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity","author":"Wegmann","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib269","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0167-4889(89)90087-6","article-title":"Characteristics of interferon induced tryptophan metabolism in human cells in\u00a0vitro","volume":"1012","author":"Werner-Felmayer","year":"1989","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib270","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00001756-200504250-00001","article-title":"Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosis","volume":"16","author":"Weydt","year":"2005","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib271","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0304-3940(89)90609-5","article-title":"Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system","volume":"97","author":"Whetsell","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib272","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s007020200014","article-title":"Increased neopterin production and tryptophan degradation in advanced Parkinson's disease","volume":"109","author":"Widner","year":"2002","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib273","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jneuroim.2003.08.042","article-title":"Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegeneration","volume":"144","author":"Wilms","year":"2003","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib274","doi-asserted-by":"crossref","unstructured":"Winhammar, J.M.C., Rowe, D.B., Henderson, R.D., Kiernan, M.C., 2005. Assessment of disease progression in motor neuron disease, 24\u201330.","DOI":"10.1016\/S1474-4422(05)70042-9"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib275","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.neuroscience.2006.07.048","article-title":"Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival","volume":"143","author":"Wootz","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib276","doi-asserted-by":"crossref","first-page":"10851","DOI":"10.1523\/JNEUROSCI.1630-10.2010","article-title":"Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice","volume":"30","author":"Xu","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib277","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nn2047","article-title":"Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis","volume":"11","author":"Yamanaka","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib278","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.celrep.2012.08.025","article-title":"FUS-SMN protein interactions link the motor neuron diseases ALS and SMA","volume":"2","author":"Yamazaki","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib279","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.neuroscience.2005.04.056","article-title":"Quinolinic acid promotes albumin deposition in Purkinje cell, astrocytic activation and lipid peroxidation in fetal brain","volume":"134","author":"Yan","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib280","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1073\/pnas.83.17.6622","article-title":"Interferon enhances tryptophan metabolism by inducing pulmonary indoleamine 2,3-dioxygenase: its possible occurrence in cancer patients","volume":"83","author":"Yasui","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib281","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1093\/nar\/gkv157","article-title":"U1 snRNP is mislocalized in ALS patient fibroblasts bearing NLS mutations in FUS and is required for motor neuron outgrowth in zebrafish","volume":"43","author":"Yu","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2016.05.011_bib282","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s13311-015-0336-z","article-title":"Being PRO-ACTive: what can a clinical trial database reveal about ALS?","volume":"12","author":"Zach","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2016.05.011_bib283","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4161\/auto.7.4.14541","article-title":"Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Zhang","year":"2011","journal-title":"Autophagy"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081630209X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081630209X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T09:59:31Z","timestamp":1718618371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081630209X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":287,"alternative-id":["S002839081630209X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.05.011","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}